Clinical Trial Update: Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vaccination against pertussis, tetanus, and diphtheria in patients with rheumatoid arthritis; study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Diphtheria toxoid vaccine (diphtheria toxoid)
• Pertussis vaccine (acellular) (pertussis vaccine (acellular))
• Tetanus toxoid vaccine (tetanus toxoid)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN